1. Introduction
Essential oils, also known as volatile oils or ethereal oils, are aromatic oily liquids extracted from different parts of the plants [1] and contain a wide range of chemical compounds, mainly terpenes and terpenoids [2]. The number of identified essential oils has reached 3000, and most have been used in many applications, namely pharmaceuticals, fragrances, and the food industry [3]. Some of these have been used to treat certain organ and systemic disorders [4]. Essential oils exhibit powerful antibacterial, antifungal, antioxidant, antiviral, anti-inflammatory, and anticancer properties [5,6,7]. A plethora of active constituents with high biological values have been found in essential oils, especially such possessing antimicrobial characteristics [8,9].
The Paramignya genus is a member of the Rutaceae family, including 28 species. The extraction of the Paramignya species comprised a wide range of chemical constituents such as coumarins, triterpenes, alkaloids, and glycoside derivatives. The Paramignya species were employed in traditional medication treating cancer, hepatitis, diabetes and nose infections. Particularly, their extracted-active compounds exhibited anti-tumour, antioxidant, and anti-inflammatory effects [10]. However, to date, there have not been many attempts on investigating the chemical compositions and biological activities of essential oils extracted from these species. Paramignya trimera (Oliv.) Guillaum (P. trimera) is a woody species and is widely distributed in the South of Vietnam [11]. The stems and roots have been traditionally applied in the treatment of liver illness and diabetes [12]. Our previous research indicated that β-caryophyllene (10.5%), β-caryophyllene oxide (9.9%), 7-epi-α-eudesmol (7.6%), and γ-muurolene (6.8%) were major constituents of the P. trimera essential oil [12].
The genus Limnocitrus includes the only known species Limnocitrus littoralis (Miq.) Swingle (L. littoralis) and is known as an endangered species in the Red List of the International Union for Conservation of Nature [13]. L. littoralis Swingle is a knotty shrub species and is naturally distributed in the coastal areas of Indonesia and the Middle and South of Vietnam [13]. In Vietnamese traditional medicine, the parts of L. littoralis have been utilised to treat fevers and colds and have antipyretic and antitussive effects [14]. The extraction of L. littoralis has been used in cosmetics to reduce non-pathological skin appearances of inflammatory origin [14]. We identified the main components of L. littoralis essential oil such as myrcene (24.9%), γ–murolene (11.0%), and oleic acid (10.3%) [14].
Along these lines, in order to give additional information about biological activities of essential oils from P. trimera and L. littoralis collected in Vietnam, we report for the first time the biological activities of the essential oils from the leaves of P. trimera and L. littoralis. The aim of this study is to determine the cytotoxicity, antiviral, antibacterial, and antimycotic and antitrichomonas effects of essential oils extracted from the leaves of P. trimera and L. littoralis. 2. Results 2.1. Cytotoxicity and Antiviral Activity
Herein, we explored antiviral properties of essential oils extracted from leaves of P. trimera and L. littoralis against RNA and DNA viruses of several important human pathogens. First, the studied ssRNA+ viruses included the following: human immunodeficiency virus type-1 (HIV-1) (Retroviridae); two Flaviviridae, bovine viral diarrhoea virus (BVDV) and yellow fever virus (YFV); and two Picornaviridae, human enterovirus B (coxsackie virus B4, CV-B4) and human enterovirus C (polio virus type-1, Sb-1). Second, the ssRNA- viruses in this case contained human respiratory syncytial virus (hRSVA2) (Pneumoviridae) and vesicular stomatitis virus (VSV) (Rhabdoviridae). Third, among dsRNA viruses, we tested reovirus type-1 (Reo-1) (Reoviridae). Finally, representatives of two DNA virus families were also included: vaccinia virus (VV) (Poxviridae) and human herpes virus 1 (herpes simplex type-1, HSV-1) (Herpesviridae). In order to understand their selective antiviral activities, the cytotoxicity tests were undertaken in parallel assays with uninfected cell lines, including MT-4 cells (CD4+ human T-cells containing an integrated HTLV-1 genome), Madin Darby Bovine Kidney (MDBK) (ATCC CCL 22 (NBL-1) Bos taurus), Baby Hamster Kidney (BHK-21) (ATCC CCL 10 (C-13) Mesocricetus auratus); Monkey kidney (Vero-76) (ATCC CRL 1587 Cercopithecus Aethiops). In vitro cytotoxicity was measured based on cell proliferation and viability. The CC50 (drug concentration inhibiting cell growth by 50% referred to untreated control) was >100 µg/mL, and no cell toxic effect was observed. However, results obtained from our screening showed that P. trimera and L. littoralis essential oils were completely ineffective against the tested viruses with EC50 values over 100 µg/mL (Table 1).
2.2. Antimicrobial Activities
The antimicrobial activities of essential oils from P. trimera and L. littoralis are displayed in Table 2. In general, Gram-positive bacteria were more sensitive to P. trimera oil than Gram-negative bacteria, whereas L. littoralis oil did not show any significant activity on both Gram-positive and Gram-negative strains. For Candida species, P. trimera and L. littoralis oils indicated the best antimicrobial activity against Candida parapsilosis (C. parapsilosis). Particularly, for P. trimera oil, i) it exhibited strongest inhibition against Staphylococcus aureus (S. aureus) with Minimum Inhibitory Concentrations (MIC) and Minimum Lethal Concentrations (MLC) values of 2% (v/v); ii) it showed MIC and MLC values of 8% (v/v) in C. parapsilosis; iii) the remaining strains had MIC and MLC values greater than or equal to 16% (v/v). For L. littoralis oil, i) it displayed strongest inhibition against Candida tropicalis (C. tropicalis) and C. parapsilosis with 2% (v/v) MIC and MLC; ii) the remaining strains possessed MIC and MLC more than or equal to 16% (v/v). The microbicidal or microbiostatic action is indicated via the ratio of MLC/MIC, whose value less than or equal to 4.0 shows a microbicidal effect, whilst that greater than 4.0 shows that it exerts a microbiostatic action [15,16]. Herein, the MLC/MIC ratios obtained from the experimental data were all equal to 1, proving that both P. trimera and L. littoralis essential oils showed bactericidal and fungicidal properties on the studied strains.
2.3. Antitrichomonas Activity
As shown in Table 3, both tested essential oils have a cytotoxic activity against Trichomonas vaginalis (T. vaginalis). It can be observed that the values of 50% inhibitory concentration (IC50), ≥90% inhibitory concentration (IC90) and MLC values against T. vaginalis were time-dependent in the given period. Essential oils showed a weak effect after 1 h of incubation, which promptly increased over time. Both P. trimera and L. littoralis essential oils strongly affected T. vaginalis viability at 24 h with a 64- and 32-fold increase, respectively, compared to 1 h. At 48 h, the antitrichomonas activity of P. trimera and L. littoralis oils increased 2 times and 4 times more than those of 24 h, respectively. In particular, the leaves-extracted oils had IC50, IC90, and MLC values, respectively, at 0.016%, 0.03%, and 0.06% (v/v) from P. trimera, and 0.03%, 0.06%, 0.12% (v/v) from L. littoralis after 48 h.
3. Discussion
Essential oils comprise a myriad of more than 20 active molecules with variable low molecular weight at distinct concentrations [17]. Essential oils can exert antimicrobial properties thanks to the complex interactions between their constituents, including phenols, alcohols, aldehydes, ketones, esters, ethers, and hydrocarbons [17], or being associated with their major components [18,19]. Each substituent of the essential oil displays a variety of mechanisms of action or cellular pathways against microorganisms [1] and modulates the effects of other components present in the same essential oil [17]. Therefore, a broad range of different chemical compositions in the essential oils are likely to result in their disparate biological properties. As an example, essential oils bearing high amounts of phenolic derivatives such as carvacrol and thymol were demonstrated to exhibit strong antimicrobial effect against bacteria [1]. In addition, the abundant oxygenated monoterpenes in essential oils were reported to show higher antibacterial effect compared to those with monoterpene hydrocarbons [20]. The essential oil of P. trimera consisted of two main classes: oxygenated sesquiterpenes (41.7%) and sesquiterpene hydrocarbons (39.6%) with major constituents, namely β-caryophyllene (10.5%), β-caryophyllene oxide (9.9%), 7-epi-α-eudesmol (7.6%), and γ-muurolene (6.8%) [12]. On the other hand, the main compounds of L. littoralis oil were classified into two main categories: sesquiterpene hydrocarbons (32.3%) and monoterpene hydrocarbons (27.7%), in which myrcene (24.9%), γ-muurolene (11.0%), and oleic acid (10.3%) were found as major constituents [14]. In the present work, it can be seen that the differences of chemical compositions between P. trimera and L. littoralis essential oils, especially their main constituents ultimately induced the distinct antimicrobial activities.
Among the above-studied bacteria, the P. trimera essential oil showed enhanced sensitivity in Gram-positive bacteria than Gram-negative ones. In fact, Gram-negative bacteria are made up of more complex cell walls than those of Gram-positive bacteria, thus rendering Gram-positive bacteria more susceptible to penetration of the essential oil to inhibit the bacteria [21,22]. Herein, we indicated that the essential oil of P. trimera was more effective against S. aureus compared to Enterococcus faecalis, while L. littoralis essential oil did not show any activity towards Gram-positive bacteria. This is hypothetically attributed to the difference in chemical compositions of these oils. The antibacterial activity of P. trimera essential oil against S. aureus was likely due to its major compounds such as β-caryophyllene and β-caryophyllene oxide. According to Dahham et al. [23], β-caryophyllene from Aquilaria crassna essential oil inhibited S. aureus with an MIC value of 3 ± 0.4 (µM). Ali et al. [24] demonstrated that Teucrium yemense essential oil contains high levels of β-caryophyllene and that caryophyllene oxide has the ability to inhibit S. aureus with an MIC value of 0.156 mg/mL.
S. aureus is one of the most common causes of nosocomial infections and postsurgical wound contamination. It is also considered as one of the main etiologic contributions in food-related infections. Moreover, the development of S. aureus-resistant methicillin has gained rapidly growing attention over the last decade [25]. In the context of traditional medicine research, some studies have focused on investigating the efficacy of some essential oils against both Methicillin-sensitive and Methicillin-resistant S. aureus. It was reported that Melaleuca alternifolia oil was effective against S. aureus with MIC90 of 0.5% (v/v) and Methicillin-resistant S. aureus with MIC90 at 0.32% (v/v) [26]. Kwiatkowski et al. [27] indicated that Carum carvi, Pogostemon cablin, and Pelargonium graveolens essential oils showed efficiency against S. aureus with MIC values of 1.88 ± 1.03, 0.17 ± 0.08, and 0.54 ± 0.20% (v/v), respectively. The growth of the standard and clinical isolates of Methicillin-resistant S. aureus and Methicillin-sensitive S. aureus were inhibited by Zataria multiflora essential oil at concentrations of 0.55 to 1.41 µL/mL [25]. On the other hand, in the current work, P. trimera oil displayed inhibition against S. aureus with MIC and MLC of 2% (v/v) and exhibited no cell toxic effect at the same concentration, and thus P. trimera oil could be used safely at this dose. However, further testing needs to be done to study the mutagenicity, teratogenicity, or other side effects before considering using it as an agent against S. aureus.
Candida species are involved in mucocutaneous infections and are considered as one the most common causes of blood-stream infections. However, over the last decade, some clinical isolates of Candida species have been developing great resistance against the conventional use of triazole antifungal drugs such as itraconazole and fluconazole; therefore, the demand for newly effective antifungals is urgently needed [25]. Indeed, essential oils can be employed as anti-Candida agents against azole-resistant strains [28]. Vishnu et al. [28] investigated 30 essential oils against C. albicans, of which 18 were found to be effective; particularly eucalyptus and peppermint oils were proved to be the most effective. Nidhi et al. [29] reported the antimicrobial activities of olive and cinnamon oils on 100 Candida isolates, and around 50% of these Candida species exhibited sensitivity against the two studied oils. C. tropicalis and C. parapsilosis were more sensitive to the L. littoralis oil compared to the other Candida species tested, and C. parapsilosis was more sensitive to the P. trimera oil compared to the other Candida species in the present study. Given the experimental data obtained in this case and our previous works [30,31], the resistance may vary depending on the species of Candida and the essential oils. The current work indicated that L. littoralis oil was effective against C. tropicalis and C. parapsilosis with MIC and MLC of 2% (v/v), while exerting no cytotoxicity at the same concentration. Therefore, L. littoralis essential oil can be used as a potent anti-Candida agent on C. tropicalis and C. parapsilosis.
T. vaginalis is a protozoan parasite and is infective agent in human vagina, prostate gland, and urethra [32]. T. vaginalis is a flagellated parasite affecting about 156 million people each year in the world [32]. Trichomoniasis infection may cause serious health consequences, especially for women [33]. The current treatment is being based upon 5-nitroimidazole [33]. However, the emergence of resistance has limited the effectiveness of this therapy [34,35]. Therefore, it is of critical importance to search for novel pharmaceutical alternatives to treat trichomoniasis successfully in clinical settings [36]. Only a few essential oils, especially some species of the Lamiaceae family, have been investigated against Trichomonas [32,36,37,38,39]. Particularly, the essential oil of Marrubium vulgare displayed antitrichomonas activity with an average MIC value of 291 ± 136 µg/mL after 48 h of incubation [36]. Hayam et al. [37] investigated the in vitro effects of Ocimum basilicum essential oil on T. vaginalis trophozoites and showed its MLC values of 30, 20, and 10 µg/mL after 24 h, 48 h, and 96 h of incubation, respectively. The previous study has demonstrated that low (≤1%) concentrations of two Lavandula essential oils (L. angustifolia and L. intermedia) can completely eliminate T. vaginalis in vitro [39]. After Amomum tsao-ko essential oil treatment, a series of modifications were observed in T. vaginalis cells. For example, nuclear membrane was disrupted, nuclei were dissolved, ribosomes were reduced, rough endoplasmic reticulum dilated, various vacuoles appeared, and organelles disintegrated. Furthermore, the cell membrane was partially damaged, and a leak of cytoplasmic led to cell disintegration [40]. In this work, we observed a prompt cytopathic activity of P. trimera and L. littoralis essential oils against T. vaginalis. Our results suggest further investigation since they could represent promising trichomonacidal agents.
Multidrug resistance is of great concern around the world and has caused a large number of deaths worldwide over the last decade [41]. Every day, bacteria and viruses have been advancing their resistance mechanisms against our current anti-infectious medications at a dramatic pace, making it exceptionally difficult to cope with given the available tools [34,35,42,43]. Furthermore, the use of synthetic chemicals to control microorganisms is facing several limitations due to their carcinogenic effects, acute toxicity, and environmental hazards [2]. As a result, it is of utmost importance to design novel antibiotics with high efficiency and non-toxicity [21]. To this end, plant-based therapeutic agents have gained extensive attention as a potential natural source for treating infectious diseases over the last few years [31,40,44]. For this reason, the present work, for the first time, discussed the cytotoxicity, antiviral, antibacterial, antimycotic, and antitrichomonas effects of essential oils from P. trimera and L. littoralis, showing great activity against S. aureus, C. tropicalis, C. parapsilosis, and T. vaginalis. Further research is needed on the biological effects as well as the toxicity of P. trimera and L. littoralis essential oils, before considering using them as therapeutic agents to treat infectious diseases.
4. Materials and Methods 4.1. Plant Material The leaves of P. trimera and L. littoralis were collected from Hue and Quang Ngai provinces, Vietnam, respectively, in May 2019. Plant samples were identified by Dr. Chinh Tien Vu, Vietnam National Museum of Nature. Two voucher specimens (TTH-T110 and QNG-T112) were deposited at the Faculty of Pharmacy, Hue University of Medicine and Pharmacy, Vietnam. 4.2. Extraction of the Essential Oils
The leaves of P. trimera and L. littoralis were shredded, and the essential oils were hydrodistilled for 3.5 h at ambient pressure using a Clevenger-type apparatus [45]. The oils were dried on Na2SO4 and stored in sealed vials, at 4 °C, ready for the biological activities test.
4.3. Cells and Cytotoxicity Assays All cells were purchased from American Type Culture Collection (ATCC). MT-4 cells (CD4+ human T cells containing an integrated HTLV-1 genome) were cultured in Roswell Park Memorial Institute 1640 (RPMI-1640) medium supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin G, and 100 μg/mL streptomycin; Madin Darby Bovine Kidneys (MDBK) (ATCC CCL 22 (NBL-1) Bos taurus) were cultured in Minimum Essential Medium with Earle’s salts (MEM-E), L-glutamine, 1mM sodium pyruvate and 25mg/L kanamycin, supplemented with 10% horse serum; Baby Hamster Kidneys (BHK-21) (ATCC CCL 10 (C-13) Mesocricetus auratus) were cultured in (MEM-E), L-glutamine, 1mM sodium pyruvate and 25 mg/L kanamycin, supplemented with 10% FBS; and Monkey kidneys (Vero-76) (ATCC CRL 1587 Cercopithecus Aethiops) were cultured in in Dulbecco’s Modified Eagle Medium (D-MEM) with L-glutamine and 25 mg/L kanamycin, supplemented with 10% FBS. Cells were checked regularly for the absence of mycoplasma contamination with MycoTect Kit (Gibco).
MT-4, BHK-21, MDBK, and Vero-76 cells were seeded at 4 × 105 cells/mL, 6 × 105 cells/mL, 1 × 106 cells/mL, and 5 × 105 cells/mL, respectively. Cell cultures were treated with varying concentrations of essential oils ranging from 0.8–100 μg/mL. Equivalent DMSO concentration were also added as control and then incubated at 37 °C in a humidified, 5% CO2 atmosphere. Cell viability was determined at 37 °C by the 3-(4,5-dimethylthiazol-1-yl)-2,5-diphenyltetrazolium bromide (MTT) method [46]. The test medium used for the cytotoxic assay as well as for antiviral assay contained 1% of the appropriate serum. DMSO was used as control in each experiment, and it was tested at the maximum concentration present in each compounds. The cytotoxicity of test compounds was evaluated in parallel with their antiviral activity.
4.4. Viruses and Antiviral Assays All viruses were purchased from American Type Culture Collection (ATCC), with the exclusion of Human Immunodeficiency Virus type-1 (HIV-1) and Yellow Fever Virus (YFV): IIIB laboratory strain of HIV-1 was obtained from the supernatant of the acutely infected H9/IIIB cells (NIH 1983); yellow fever virus (YFV) (strain 17-D vaccine (Stamaril Pasteur J07B01)); bovine viral diarrhoea virus (BVDV) (strain NADL (ATCC VR-534)); coxsackie type B4 (CV-B4) (strain J.V.B. (ATCC VR-184)); human enterovirus C (poliovirus type-1 (Sb-1) (Sabin strain Chat (ATCC VR-1562)); vesicular stomatitis virus (VSV) (lab strain Indiana (ATCC VR 1540)); human respiratory syncytial virus (hRSV) (strain A2 (ATCC VR-1540)); reovirus type-1 (Reo-1) (simian virus 12, strain 3651 (ATCC VR- 214)), vaccinia virus (VV) (vaccine strain Elstree-Lister (ATCC VR-1549)); human herpes 1 (HSV-1) (strain KOS (ATCC VR-1493)).Viruses were maintained in our laboratory and propagated in suitable cell lines. The viruses were stored in small aliquots at −80 °C until use.
Essential oil’s activity against HIV-1 was evaluated as follow: 50 μL of RPMI-1640 containing 1 × 104 MT-4 cells were added to each well of flat-bottom microtitre trays, containing 50 μL of RPMI-1640 with or without serial dilutions of the essential oils. Then, 20 μL of an HIV-1 suspension containing 100 CCID50 was added. Essential oil’s activity against YFV and Reo-1 was based on inhibition of virus-induced cytopathogenicity in BHK-21 cells acutely infected at an multiplicity of infection (m.o.i) of 0.01. Essential oil’s activity against BVDV was based on inhibition of virus-induced cytopathogenicity in MDBK cells acutely infected at an m.o.i. of 0.01. Briefly, BHK and MDBK cells were seeded in 96-well plates at a density of 5 × 104 and 3 × 104 cells/well, respectively, and were allowed to form confluent monolayers by incubating overnight in growth medium at 37 °C in a humidified CO2 (5%) atmosphere. Cell monolayers were then infected with 50 μL of a proper virus dilution in MEM-E, then 50 μL of medium, with or without serial dilutions of the essential oils. After a 3- or 4-day incubation at 37 °C, cell viability was measured by the MTT method [46].
Activities of essential oils and compounds against CV-B4, Sb-1, VV, VSV, hRSV A2, and HSV-1 was determined by plaque reduction assays in infected cell monolayers as described previously [47]. Briefly, Vero-76 cells were cultured in 24-well tissue culture plate and with approximately 50/100 PFU/well of virus. After 2 h on a rocker, the unadsorbed viruses were removed and replaced with 500 μL of D-MEM containing 0.75% methyl-cellulose, with serial dilutions of test products. The overlayed medium was also added to not treat wells as non-infection controls. Cultures were incubated at 37 °C and then fixed with PBS containing 50% ethanol and 0.8% crystal violet, washed and air-dried. The number of plaques in the control (no inhibitor) and experimental wells were then counted.
4.5. Antimicrobial Activities In the present work, a collection of 12 strains were selected, including 5 Gram-negative strains (Escherichia coli ATCC 35218, Escherichia coli clinical, Pseudomonas aeruginosa ATCC 27853, Pseudomonas aeruginosa clinical and Klebsiella pneumoniae clinical); 3 Gram-positive strains (Staphylococcus aureus ATCC 43300, Staphylococcus aureus clinical and Enterococcus faecalis clinical); and 4 Candida species strains (Candida albicans 556 RM, Candida glabrata clinical, Candida tropicalis 1011 RM and Candida parapsilosis RM). Cultures were maintained in appropriate media at 4 °C. The cells were cultivated at 37 °C on agar plates for 18 h prior to experiments. 4.6. Determination of Minimum Inhibitory Concentrations (MIC) and Minimum Lethal Concentration (MLC)
In order to establish the MIC and MLC of bacteria and Candida species, the broth dilution method was employed as reported by the Clinical and Laboratory Standard Institute [48]. The inoculum was prepared by diluting colonies in salt solution at a concentration of 0.5 McFarland, then confirmed at a wavelength of 530 nm by a spectrophotometric reading. The sensitivity test was implemented in Luria Bertani broth and RPMI-1640 medium using 96-well plates. The oil solutions were diluted to a range of concentrations from 16% (v/v) to 5 × 10−4% (v/v). After shaking, 100 μL of each oil dilution and 100 μL of bacterial/yeast suspension at a concentration of 106 CFU/mL were added to each well and then incubated within 24 h for bacteria and 48 h for fungi at 37 °C. MIC values were determined by the lowest concentration of the essential oils in which bacterial growth is visibly inhibited after overnight incubation. In order to determine the MLC values, 10 μL was seeded on Mueller Hinton agar and Sabouraud Dextrose agar and the plates were incubated within 24 h for bacteria and 48 h for fungi at 37 °C. Minimal Lethal Concentration (MLC) was considered as the lowest concentration that reduces the viability of the initial microbial inoculum by ≥99.9%. A positive growth control consisting of organisms in broth and a negative sterility control consisting of uninoculated broth were included for each assay. Each experiment was performed in duplicate and repeated three times.
4.7. Antitrichomonas Activity
Trichomonas vaginalis were cultured axenically in vitro by daily passages in Diamond’s Trypticase Yeast extract Maltose (TYM) medium (Sigma Chemical Co., St. Louis, MO, USA) plus 10% FBS (GIBCO, Invitrogen) at 37 °C in a 5% carbon dioxide atmosphere [49]. Exponentially growing T. vaginalis cells were harvested and viability was assessed by microscopy. Trichomonas cells (viability >95%) were centrifuged at 1500 rpm for 10 min and resuspended in Diamond’s TYM medium at a concentration of 2 × 105 cells/mL [50].
Essential oils from P. trimera and L. littoralis were serially diluted in 100 μL of Diamond’s TYM medium from 16% to 0.002% (v/v) in 96-well plates, and 100 μL of the prepared Trichomonas suspension was added to each well. Diamond’s TYM medium alone was used as a growth control. The culture plate was kept at 37 °C in a CO2 incubator and checked after 1, 4, 24, and 48 h. The percentage of viable T. vaginalis cells was assessed by microscopic observation. The MLC was defined as the lowest essential oils concentration in which no viable protozoa were observed. The IC50 and IC90 values were considered as the oils concentration in which 50% and ≥90% T. vaginalis cells were killed. Each assay has been repeated independently at least two times [40].
4.8. Linear Regression Analysis and Statistical Analysis The extent of cell growth/viability and viral multiplication, at each drug concentration tested, were expressed as percentage of untreated controls. Concentrations resulting in 50% inhibition (CC50 or EC50) were determined by linear regression analysis. Data were processed for ANOVA by means of the software MSTAT-C, and mean separation was performed by application of the LSD test at p ≤ 0.05 level of significance. 5. Conclusions The biological activities of P. trimera and L. littoralis essential oils were determined for the first time. Both oils displayed no cytotoxicity on normal cells such as MT-4, BHK-21, MDBK, and Vero-76. The P. trimera oil displayed the strongest sensitivity against S. aureus, whereas that of L. littoralis exhibited the strongest inhibition towards C. tropicalis and C. parapsilosis, with MIC and MLC values of 2% (v/v). In addition, P. trimera essential oil inhibited C. parapsilosis as observed in MIC and MLC of 8% (v/v). The oils also demonstrated inhibition against T. vaginalis with IC50, IC90, and MLC, respectively, at 0.016%, 0.03%, and 0.06% (v/v) from P. trimera and 0.03%, 0.06%, and 0.12% (v/v), respectively, from L. littoralis after 48 h of incubation. These studied essential oils were ineffective against HIV-1, YFV, BVDV, Sb-1, CV- B4, RSV, VSV, Reo-1, HSV-1, and VV viruses. Further studies should be implemented to evaluate the safety and toxicity of P. trimera and L. littoralis essential oils in humans before considering the development new anti-infectious agents for use in clinical trials.
| Cell Lines and Virus | MT-4 | HIV-1IIIB | BHK-21 | YFV | Reo-1 | MDBK | BVDV | Vero-76 | RSV | VSV | HSV-1 | VV | Sb-1 | CV-B4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CC50 a | EC50 b | CC50 c | EC50 d | EC50 d | CC50 e | EC50 f | CC50 g | EC50 h | ||||||
| O.P.t | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
| O.L.l | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
| * Reference Compound | ||||||||||||||
| RC1 | 40 | 0.003 ± 0.0003 | - | - | - | - | - | - | - | - | - | - | - | - |
| RC2 | - | - | 80 | 1.4 ± 0.2 | - | >100 | 1.7 ± 0.3 | - | - | - | - | - | - | - |
| RC3 | - | - | - | - | - | - | - | >100 | - | - | - | - | 2 | 2 ± 0.5 |
| RC4 | - | - | - | - | - | - | - | ≥14 | 2 ± 0.2 | - | - | - | - | - |
| RC5 | - | - | - | - | - | - | - | >100 | - | - | 3.0 ± 0.1 | - | - | - |
| RC6 | - | - | - | - | - | - | - | >100 | - | - | - | 1.7 ± 0.1 | - | - |
| RC7 | - | - | >100 | - | 17 | - | - | - | - | - | - | - | - | - |
Data represent mean values + standard deviation (SD) for three independent determinations. For values where SD is not shown, variation among duplicate samples was less than 15%. O.P.t: essential oil from the leaves of Paramignya trimera; O.L.l: essential oil from the leaves of Limnocitrus littoralis; RC1: Efavirenz; RC2: 2′-C-methylguanosine; RC3: Pleconaril; RC4: 6-aza-uridine; RC5: Acycloguanosine; RC6: Mycophenolic acid; RC7: 2′-C-methylcytidine. a Compound concentration (µg/mL) required to reduce the proliferation of mock-infected MT-4 cells by 50%, as determined by the 3-(4,5-dimethylthiazol-1-yl)-2,5-diphenyltetrazolium bromide (MTT) method. b Compound concentration (µg/mL) required to achieve 50% protection of MT-4 cells from HIV-1-induced cytopathogenicity, as determined by the MTT method. c Compound concentration (µg/mL) required to reduce the viability of mock-infected Baby Hamster Kidney (BHK) cells by 50%, as determined by the MTT method. d Compound concentration (µg/mL) required to achieve 50% protection of BHK cells from yellow fever virus (YFV) or Reo-1 induced cytopathogenicity, as determined by the MTT method. e Compound concentration (µg/mL) required to reduce the viability of mock-infected Madin Darby Bovine Kidney (MDBK) cells by 50%, as determined by the MTT method. f Compound concentration (µg/mL) required to achieve 50% protection of MDBK cells from bovine viral diarrhoea virus (BVDV)-induced cytopathogenicity, as determined by the MTT method. g Compound concentration (µg/mL) required to reduce the viability of mock-infected Vero-76 cells by 50%, as determined by the MTT method. h Compound concentration (µg/mL) required to reduce the plaque number of RSV, VSV, HSV-1, VV, Sb-1, and CV-B4 by 50% in Vero-76 monolayers. * Reference compound: CC50 and EC50 are in µM.
| Strains | P. trimera Oil | L. littoralis Oil | ||
|---|---|---|---|---|
| MIC (% v/v) | MLC (% v/v) | MIC (% v/v) | MLC (% v/v) | |
| Gram-Positive Bacteria | ||||
| Staphylococcus aureus ATCC 43300 | 2 ± 0.5 | 2 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 |
| Staphylococcus aureus clinical strain | 2 ± 0.5 | 2 ± 0.5 | >16 ± 0.5 | >16 ± 1 |
| Enterococcus faecalis clinical strain | 16 ± 0.5 | 16 ± 1 | >16 ± 1 | >16 ± 1 |
| Gram-Negative Bacteria | ||||
| Escherichia coli ATCC 35218 | >16 ± 1 | >16 ± 1 | >16 ± 1 | >16 ± 0.5 |
| Escherichia coli clinical strain | >16 ± 1 | >16 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 |
| Pseudomonas aeruginosa ATCC 27853 | 16 ± 0.5 | >16 ± 1 | >16 ± 1 | >16 ± 1 |
| Pseudomonas aeruginosa clinical strain | 16 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 | >16 ± 1 |
| Klebsiella pneumoniae clinical strain | >16 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 | >16 ± 1 |
| Yeast | ||||
| Candida albicans 556 RM | 16 ± 1 | 16 ± 0.5 | 16 ± 0.5 | 16 ± 1 |
| Candida glabrata clinical | 16 ± 1.5 | 16 ± 1 | >16 ± 0.5 | >16 ± 0.5 |
| Candida tropicalis 1011 RM | 16 ± 0.5 | 16 ± 1 | 2 ± 0.5 | 2 ± 0.5 |
| Candida parapsilosis RM | 8 ± 0.5 | 8 ± 0.5 | 2 ± 0.5 | 2 ± 0.5 |
MIC and MLC values represent the mean ± SD of three independent experiments. MIC: Minimum Inhibitory Concentrations. MLC: Minimum Lethal Concentrations.
| Time | P. trimera Oil | L. littoralis Oil | ||||
|---|---|---|---|---|---|---|
| IC50 | IC90 | MLC | IC50 | IC90 | MLC | |
| 1 h | 2 | 4 | 8 | 2 | 8 | 16 |
| 4 h | 0.5 | 1 | 2 | 1 | 4 | 8 |
| 24 h | 0.03 | 0.06 | 0.12 | 0.12 | 0.25 | 0.5 |
| 48 h | 0.016 | 0.03 | 0.06 | 0.03 | 0.06 | 0.12 |
Data represent mean values for two independent experiments. IC50: The concentration that causes 50% Trichomonas growth inhibition (% v/v). IC90: The concentration that causes ≥ 90% Trichomonas growth inhibition (% v/v). MLC: The concentration that causes the death of 100% Trichomonas (% v/v).
Author Contributions
Conceptualization, D.U., P.C. and M.G.D.; Data curation, D.U. and H.T.N.; Formal analysis, D.U., H.T.N. and M.G.D.; Funding acquisition, P.C., S.Z. and M.G.D.; Investigation, A.R., D.U., G.S., S.Z., H.T.N. and M.G.D.; Methodology, N.T.L., T.Q.D., G.S., A.T.L., D.U. and M.G.D.; Project administration, P.C., S.Z., H.T.N. and M.G.D.; Resources, P.C., S.Z. and M.G.D.; Software, D.U. and M.G.D.; Supervision, P.C., S.Z., H.T.N. and M.G.D.; Validation, D.U., P.C., S.Z. and H.T.N.; Visualization, D.V.H., T.Q.D., A.T.L., A.R., D.U., G.S., A.C., P.R., N.D., P.C., S.Z. and M.G.D.; Writing-original draft, N.T.L., D.U. and M.G.D.; Writing-review & editing, N.T.L., D.U. and M.G.D. All authors have read and agree to the published version of the manuscript.
Funding
This research received no external funding.
Acknowledgments
We feel thankful for the support of colleagues at the University of Sassari and University of Cagliari who enabled us to complete the present work. The data used to support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
1. Burt, S. Essential oils: Their antibacterial properties and potential applications in foods-A review. Int. J. Food Microbiol. 2004, 94, 223-253.
2. Swamy, M.K.; Akhtar, M.S.; Sinniah, U.R. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: An updated review. Evid.-Based Complement. Altern. Med. 2016, 2016, 1-21.
3. De Andrade, T.U.; Brasil, G.A.; Endringer, D.C.; Da Nóbrega, F.R.; De Sousa, D.P. Cardiovascular activity of the chemical constituents of essential oils. Molecules 2017, 22, 1539.
4. Paola Angelini, A.P. Some Biological Activities of Essential Oils. Med. Aromat. Plants 2012, 2, 2-5.
5. Perricone, M.; Arace, E.; Corbo, M.R.; Sinigaglia, M.; Bevilacqua, A. Bioactivity of essential oils: A review on their interaction with food components. Front. Microbiol. 2015, 6, 1-7.
6. Shaaban, H.A.E.; El-Ghorab, A.H.; Shibamoto, T. Bioactivity of essential oils and their volatile aroma components: Review. J. Essent. Oil Res. 2012, 24, 203-212.
7. Blowman, K. Anticancer Properties of Essential Oils and Other Natural Products. Anat. Rec. 2018, 8, 525-551.
8. Prabuseenivasan, S.; Jayakumar, M.; Ignacimuthu, S. In vitro antibacterial activity of some plant essential oils. BMC Complement. Altern. Med. 2006, 6, 1-8.
9. Bua, A.; Usai, D.; Donadu, M.G.; Delgado Ospina, J.; Paparella, A.; Chaves-Lopez, C.; Serio, A.; Rossi, C.; Zanetti, S.; Molicotti, P. Antimicrobial activity of Austroeupatorium inulaefolium (H.B.K.) against intracellular and extracellular organisms. Nat. Prod. Res. 2018, 32, 2869-2871.
10. Son, N.T. Notes on the genus Paramignya: Phytochemistry and biological activity. Bull. Fac. Pharm. Cairo Univ. 2018, 56, 1-10.
11. Ho, P.H. Vietnamese Plants-An Illustrated Flora of Vietnam; Young publisher: Ho Chi Minh City, Vietnam, 1999; Volume 2, pp. 427-429.
12. Tuan, D.Q.; Duc, H.V.; Nhan, L.T.; Anh, L.T.; Hoai, N.T.; Raal, A. Constituents of Essential Oils from the Leaves of Paramignya trimera (Oliv.) Guillaum from Vietnam. J. Essent. Oil-Bear. Plants 2019, 5026, 20-25.
13. Chi, V.V. The Dictionary of Medicinal Plants in Vietnam; Med. Publ. House: Ha Noi, Vietnam, 2012.
14. Doan, T.Q.; Ho, D.V.; Trong Le, N.; Le, A.T.; Van Phan, K.; Nguyen, H.T.; Raal, A. Chemical composition and anti-inflammatory activity of the essential oil from the leaves of Limnocitrus littoralis (Miq.) Swingle from Vietnam. Nat. Prod. Res. 2019, 20, 1-5.
15. Nkanwen, E.R.S.; Gatsing, D.; Ngamga, D.; Fodouop, S.P.C.; Tane, P. Antibacterial agents from the leaves of Crinum purpurascens herb (Amaryllidaceae). Afr. Health Sci. 2009, 9, 264-269.
16. Neta, M.C.S.; Vittorazzi, C.; Guimarães, A.C.; Martins, J.D.L.; Fronza, M.; Endringer, D.C.; Scherer, R. Effects of β-caryophyllene and Murraya paniculata essential oil in the murine hepatoma cells and in the bacteria and fungi 24-h time-kill curve studies. Pharm. Biol. 2017, 55, 190-197.
17. Sharifi-Rad, J.; Sureda, A.; Tenore, G.C.; Daglia, M.; Sharifi-Rad, M.; Valussi, M.; Tundis, R.; Sharifi-Rad, M.; Loizzo, M.R.; Oluwaseun Ademiluyi, A.; et al. Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules 2017, 22, 70.
18. Imelouane, B.; Amhamdi, H.; Wathelet, J.P.; Ankit, M.; Khedid, K.; El Bachiri, A. Chemical composition and antimicrobial activity of essential oil of thyme (Thymus vulgaris) from eastern Morocco. Int. J. Agric. Biol. 2009, 11, 205-208.
19. Li, Z.H.; Cai, M.; Liu, Y.S.; Sun, P.L.; Luo, S.L. Antibacterial Activity and Mechanisms of Essential Oil from Citrus medica L. Var. Sarcodactylis. Molecules 2019, 24, 1577.
20. Baali, F.; Boumerfeg, S.; Napoli, E.; Boudjelal, A.; Righi, N.; Deghima, A.; Baghiani, A.; Ruberto, G. Chemical Composition and Biological Activities of Essential Oils from Two Wild Algerian Medicinal Plants: Mentha pulegium L. and Lavandula stoechas L. J. Essent. Oil-Bear. Plants 2019, 22, 821-837.
21. Nazzaro, F.; Fratianni, F.; De Martino, L.; Coppola, R.; De Feo, V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals 2013, 6, 1451-1474.
22. Zeragui, B.; Hachem, K.; Halla, N.; Kahloula, K. Essential Oil from Artemisia judaica L. (ssp. sahariensis) Flowers as a Natural Cosmetic Preservative: Chemical Composition, and Antioxidant and Antibacterial Activities. J. Essent. Oil-Bear. Plants 2019, 22, 685-694.
23. Dahham, S.S.; Tabana, Y.M.; Iqbal, M.A.; Ahamed, M.B.K.; Ezzat, M.O.; Majid, A.S.A.; Majid, A.M.S.A. The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of Aquilaria crassna. Molecules 2015, 20, 11808-11829.
24. Ali, N.; Chhetri, B.; Dosoky, N.; Shari, K.; Al-Fahad, A.; Wessjohann, L.; Setzer, W. Antimicrobial, Antioxidant, and Cytotoxic Activities of Ocimum forskolei and Teucrium yemense (Lamiaceae) Essential Oils. Medicines 2017, 4, 17.
25. Zomorodian, K.; Saharkhiz, M.J.; Rahimi, M.J.; Bandegi, A.; Shekarkhar, G.; Bandegani, A.; Pakshir, K.; Bazargani, A. Chemical composition and antimicrobial activities of the essential oils from three ecotypes of Zataria multiflora. Pharmacogn. Mag. 2011, 7, 53-59.
26. Halcon, L.; Milkus, K. Staphylococcus aureus and wounds: A review of tea tree oil as a promising antimicrobial. Am. J. Infect. 2004, 32, 402-408.
27. Kwiatkowski, P.; Mnichowska-Polanowska, M.; Pruss, A.; Dzięcioł, M.; Masiuk, H. Activity of essential oils against Staphylococcus aureus strains isolated from skin lesions in the course of staphylococcal skin infections. Herba Pol. 2017, 63, 43-52.
28. Agarwal, V.; Lal, P.; Pruthi, V. Effect of Plant Oils on Candida albicans. J. Microbiol. Immunol. Infect. 2010, 43, 447-451.
29. Goel, N.; Rohilla, H.; Sing, G.; Punia, P. Antifungal activity of Cinnamon oil and Olive oil against Candida spp. Isolated from blood stream infections. J. Clin. Diagn. Res. 2016, 10, DC09-DC11.
30. Cannas, S.; Usai, D.; Tardugno, R.; Benvenuti, S.; Pellati, F.; Zanetti, S.; Molicotti, P. Chemical composition, cytotoxicity, antimicrobial and antifungal activity of several essential oils. Nat. Prod. Res. 2016, 30, 332-339.
31. Donadu, M.G.; Usai, D.; Marchetti, M.; Usai, M.; Mazzarello, V.; Molicotti, P.; Montesu, M.A.; Delogu, G.; Zanetti, S. Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis. Nat. Prod. Res. 2019, 1-5.
32. Fakhrieh Kashan, Z.; Delavari, M.; Arbabi, M.; Hooshyar, H. Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis. Iran. Biomed. J. 2017, 21, 285-293.
33. Scopel, M.; dos Santos, O.; Frasson, A.P.; Abraham, W.R.; Tasca, T.; Henriques, A.T.; Macedo, A.J. Anti-Trichomonas vaginalis activity of marine-associated fungi from the South Brazilian Coast. Exp. Parasitol. 2013, 133, 211-216.
34. Blaha, C.; Duchêne, M.; Aspöck, H.; Walochnik, J. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis. J. Antimicrob. Chemother. 2006, 57, 273-278.
35. Krashin, J.W.; Koumans, E.H.; Bradshaw-Sydnor, A.C.; Braxton, J.R.; Secor, W.E.; Sawyer, M.K.; Markowitz, L.E. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex. Transm. Dis. 2010, 37, 440-444.
36. Akbari, Z.; Dastan, D.; Maghsood, A.H.; Fallah, M.; Matini, M. Investigation of In vitro Efficacy of Marrubium vulgare L. Essential Oil and Extracts Against Trichomonas vaginalis. Zahedan J. Res. Med. Sci. 2018. in Press.
37. Ezz Eldin, H.M.; Badawy, A.F. In vitro anti-Trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil. J. Parasit. Dis. 2015, 39, 465-473.
38. Ziaei Hezarjaribi, H.; Nadeali, N.; Fakhar, M.; Soosaraei, M. Medicinal plants with anti-Trichomonas vaginalis activity in Iran: A systematic review. Iran. J. Parasitol. 2019, 14, 1-9.
39. Moon, T.; Wilkinson, J.M.; Cavanagh, H.M.A. Antiparasitic activity of two Lavandula essential oils against Giardia duodenalis, Trichomonas vaginalis and Hexamita inflata. Parasitol. Res. 2006, 99, 722-728.
40. Dai, M.; Peng, C.; Peng, F.; Xie, C.; Wang, P.; Sun, F. Anti-Trichomonas vaginalis properties of the oil of Amomum tsao-ko and its major component, geraniol. Pharm. Biol. 2016, 54, 445-450.
41. Raut, J.S.; Karuppayil, S.M. A status review on the medicinal properties of essential oils. Ind. Crop. Prod. 2014, 62, 250-264.
42. Li, B.; Webster, T.J. Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. J. Orthop. Res. 2018, 36, 22-32.
43. Cannas, S.; Molicotti, P.; Usai, D.; Maxia, A.; Zanetti, S. Antifungal, anti-biofilm and adhesion activity of the essential oil of Myrtus communis L. against Candida species. Nat. Prod. Res. 2014, 28, 2173-2177.
44. Fisher, K.; Phillips, C. Potential antimicrobial uses of essential oils in food: Is citrus the answer? Trends Food Sci. Technol. 2008, 19, 156-164.
45. Vietnamese Pharmacopoeia; Med. Publ. House: Hanoi, Vietnam, 2017.
46. Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 1988, 20, 309-321.
47. Carta, A.; Sanna, G.; Briguglio, I.; Madeddu, S.; Vitale, G.; Piras, S.; Corona, P.; Peana, A.T.; Laurini, E.; Pricl, S.; et al. Quinoxaline derivatives as new inhibitors of coxsackievirus B5. Eur. J. Med. Chem. 2017, 145, 559-569.
48. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition: M07-A9; CLSI: Wayne, PA, USA, 2012.
49. Thu, T.T.T.; Margarita, V.; Cocco, A.R.; Marongiu, A.; Dessì, D.; Rappelli, P.; Fiori, P.L. Trichomonas vaginalis Transports Virulent Mycoplasma hominis and Transmits the Infection to Human Cells after Metronidazole Treatment: A Potential Role in Bacterial Invasion of Fetal Membranes and Amniotic Fluid. J. Pregnancy 2018, 2018, 1-6.
50. Nu, P.A.T.; Nguyen, V.Q.H.; Cao, N.T.; Dessì, D.; Rappelli, P.; Fiori, P.L. Prevalence of Trichomonas vaginalis infection in symptomatic and asymptomatic women in central vietnam. J. Infect. Dev. Ctries. 2015, 9, 655-660.
Nhan Trong Le1, Duc Viet Ho1, Tuan Quoc Doan1, Anh Tuan Le2, Ain Raal3, Donatella Usai4, Giuseppina Sanna5, Antonio Carta6, Paola Rappelli4, Nicia Diaz4, Piero Cappuccinelli4,*, Stefania Zanetti4, Hoai Thi Nguyen1,* and Matthew Gavino Donadu4,6
1Faculty of Pharmacy, Hue University of Medicine and Pharmacy, Hue University, Hue 49000, Viet Nam
2Mientrung Institute for Scientific Research, VAST, Hue 49000, Viet Nam
3Institute of Pharmacy, Faculty of Medicine, University of Tartu, 50900 Tartu, Estonia
4Department of Biomedical Science, University of Sassari, 07100 Sassari, Italy
5Department of Biomedical Science, University of Cagliari, 09042 Monserrato, Italy
6Department of Chemistry and Pharmacy, University of Sassari, 07100 Sassari, Italy
*Authors to whom correspondence should be addressed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
The present study aimed to determine the bioactivities of essential oils extracted from the leaves of Paramignya trimera and Limnocitrus littoralis, including cytotoxicity, antiviral, antibacterial, antimycotic, and antitrichomonas effects. Herein, it was indicated that P. trimera and L. littoralis oils showed no cytotoxicity on normal cells, namely MT-4, BHK-21, MDBK, and Vero-76. P. trimera oil (i) exhibited the strongest inhibition against Staphylococcus aureus with MIC and MLC values of 2% (v/v); (ii) showed MIC and MLC values of 8% (v/v) in Candida parapsilosis; and (iii) in the remaining strains, showed MIC and MLC values greater than or equal to 16% (v/v). On the other hand, L. littoralis oil (i) displayed the strongest inhibition against Candida tropicalis and Candida parapsilosis with 2% (v/v) of MIC and MLC; and (ii) in the remaining strains, possessed MIC and MLC greater than or equal to 16% (v/v). In addition, antitrichomonas activities of the oils were undertaken, showing IC50, IC90, MLC values, respectively, at 0.016%, 0.03%, and 0.06% (v/v) from P. trimera, and 0.03%, 0.06%, 0.12% (v/v) from L. littoralis, after 48 h of incubation. The oils were completely ineffective against ssRNA+ (HIV-1, YFV, BVDV, Sb-1, CV-B4), ssRNA- (RSV, VSV), dsRNA (Reo-1), and dsDNA (HSV-1, VV) viruses. This is the first report describing the cytotoxicity, antiviral, antibacterial, antimycotic, and antitrichomonas activities of the essential oils of P. trimera and L. littoralis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Doan, Tuan Quoc; Anh Tuan Le
; Ain Raal
; Usai, Donatella; Sanna, Giuseppina
; Carta, Antonio; Rappelli, Paola; Diaz, Nicia; Cappuccinelli, Piero; Zanetti, Stefania; Hoai Thi Nguyen; Matthew Gavino Donadu